glp-1 news september 2025 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded semaglutide and tirzepatide – Partnership for Safe Medicines September 8, 2025: FDA launches

Description

10.1159/000092104 59 MarxN.FedericiM.SchttK.Mller-WielandD.AjjanR

The remarkable weight loss and glucose-lowering results achieved by the dual peptides paved the way for triple GIP/GLP-1/glucagon receptor triagonists with the hope that the new combinatorial approaches provide further synergistic metabolic effects

Studies show that this type of diet actually alters the circadian rhythm of GLP-1 secretion, both in lab animals and in people with type 2 diabetes.[ref] Does a decrease in natural GLP-1 secretion explain the obesity epidemic

If you're due for a screening or unsure about which prep is best for you, contact our Brooklyn office today to schedule your consultation

In rare cases, GLP-1 agonists like Ozempic have been linked with eye problems, gallbladder and pancreas problems, blocked intestines, and stomach paralysis (a condition in which your stomach muscles don't contract as they should to help you digest food)